期刊文献+

多奈哌齐治疗阿尔茨海默病患者认知功能的自然观察研究 被引量:6

Naturalistic observation of the effect of donepezil on cognitive function in Alzheimer's disease in memory clinic
原文传递
导出
摘要 目的 考察记忆门诊自然观察过程中多奈哌齐对阿尔茨海默病(AD)患者认知功能的改善作用。方法13例在记忆门诊就诊的符合NINCDS—ADRDA很可能AD诊断标准的接受多奈哌齐(5mg/d)治疗的轻中度AD患者纳入自然观察研究,采用认知功能筛查测验(CASI)评估患者认知功能,分别在治疗前、治疗3个月和6个月进行。结果与基线相比,治疗6个月时思维流畅性有显著改善(4.3±3.1与6.2±2.7,P〈0.05);构图能力呈改善趋势,但差异无统计学意义(P=0.06),其余认知功能治疗前后比较差异均无统计学意义(P均〉0.05)。结论记忆门诊自然观察条件下,多奈哌齐能改善AD患者言语流畅性,并能使患者其他认知领域功能保持基本稳定。 Objective To examine the effect of donepezil on cognitive function of Alzheimer's disease from a naturalistic observation in memory clinic. Methods From the subject pool in memory clinic, thirteen patients with mild to moderate Alzheimer's disease (meeting NINCDS-ADRDA criteria of probable AD) were enrolled in the naturalistic observation. Donepezil with dosage of 5 mg daily was administered. Cognitive Ability Screening Instrument (CASI) was used to assess the cognitive function, and was administered at baseline ,3 and 6 months after treatment with donepezil. Results After 6-month treatment with donepezil, the change of score of verbal fluency from baseline was significant [ (4.3 ±3.1 ) vs (6.2 ±2.7) ,P 〈0.05]. There was a trend that constructional praxis was also improved after 6-month treatment ( P = 0.06 ). The change of scores of other cognitive domains remained the same( P 〉 0.05). Conclusion In the naturalistic observation at memory clinic, donepezil may improve verbal fluency of AD patients, and keep most cognitive function stable.
出处 《中国综合临床》 2009年第4期345-347,共3页 Clinical Medicine of China
基金 国家自然基金(30500178)志谢:本研究得到国家自然科学基金(30500178)和美国阿尔茨海默病协会研究基金(NIRG-04-1184)的部分支持.感谢Evelyn Teng(李眉)教授馈赠CASI量表以及测查指导手册,感谢赵学英老师进行大量的认知测查工作.感谢所有参加研究的患者及其家属的志愿参与和热忱支持.
关键词 多奈哌齐 阿尔茨海默病 认知功能 自然观察 Donepezil Alzheimer's disease Cognitive function Naturalistic observation
  • 相关文献

参考文献8

  • 1Rogers SL, Farlow MR, Doody RS, et al. A 2g-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group [ J ]. Neurology, 1998,50 ( 1 ) : 136-145.
  • 2Burns A, Gauthier S, Perdomo C. Efficacy and safety of donepezil over 3 years: an open-label, muhieentre study in patients with Alzheimer's disease [ J ]. Int J Geriatr Psychiatry,2007,22 ( 8 ) : 806 -812.
  • 3彭丹涛,许贤豪,侯青云,王鲁宁,解恒革,张振馨,王荫华,杨志杰,张新卿,舒良,马辛,金弘敏,蔡琰,吕传真,陈生弟,邵福源,李文贤,俞丽华,高之旭,钱彩韵,王群,徐书雯,潘小平,朱德仪,马崔.安理申治疗轻中度阿尔茨海默病有效性及安全性的临床研究[J].中华神经科杂志,2002,35(1):19-21. 被引量:41
  • 4McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' s Disease [ J ]. Neurology, 1984,34 ( 7 ) :939 -944.
  • 5李眉,林克能,周碧瑟,付中玲,王署君,刘秀枝.知能筛查测验和三种文版的初测结果[J].中国临床心理学杂志,1994,2(2):69-73. 被引量:4
  • 6高静芳,陶明,李翼群,张明园,李眉.智能筛选测验的信度和效度测试[J].中华精神科杂志,1997,30(3):175-178. 被引量:21
  • 7Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease : measurement, rate, and predictors of cognitive deterioration[ J]. Am J Psychiatry, 1994,151 (3) :390-396.
  • 8Wang H, Yu X, Li S,et al. The cognitive subscale of Alzheimer's Disease Assessment Scale, Chinese version in staging of Alzheimer disease[J]. Alzheimer Dis Assoc Disord,2004,18(4) :231-235.

二级参考文献4

  • 1高之旭,刘福根,严和,王安生,潘健雄,王道华.认知功能筛选量表筛查老年期痴呆[J].上海精神医学,1993,5(1):20-22. 被引量:8
  • 2Teng E L,Int Psychogeriat Rics,1994年,6卷,45页
  • 3高之旭,上海精神医学,1993年,5卷,20页
  • 4李眉,智能筛检测验手册C-2.0台湾及洛杉矶南加州版本,1993年

共引文献63

同被引文献64

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部